ORASURE TECHNOLOGIES INC. - COMMON STOCK

InteliSwab® COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 Subvariants

17 May 2022 07:05:00 By Nasdaq GlobeNewswire

OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID Revenue

10 May 2022 16:05:01 By Nasdaq GlobeNewswire

OraSure Technologies, Inc. 2022 First Quarter Earnings Conference Call Tuesday, May 10, 2022, 5:00 p.m. ET

03 May 2022 16:05:00 By Nasdaq GlobeNewswire

OraSure Technologies’ Subsidiary DNA Genotek Launches the First Device with De Novo Authorization from the FDA for the Preservation and Stabilization of Microbiome Samples

07 Apr 2022 07:05:00 By Nasdaq GlobeNewswire

OraSure Technologies’ Subsidiary Diversigen Launches Metatranscriptomic Sequencing and Analysis Services for Gut Microbiome Samples

31 Mar 2022 07:05:00 By Nasdaq GlobeNewswire

OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensive Diagnostics and Healthcare Leadership Experience to Role

22 Mar 2022 16:05:00 By Nasdaq GlobeNewswire

OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up

23 Feb 2022 16:05:01 By Nasdaq GlobeNewswire

OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022, 5:00 p.m. ET

16 Feb 2022 16:05:01 By Nasdaq GlobeNewswire

InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App

31 Jan 2022 07:05:00 By Nasdaq GlobeNewswire

OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe

25 Jan 2022 07:05:00 By Nasdaq GlobeNewswire

InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants

13 Jan 2022 16:05:00 By Nasdaq GlobeNewswire

OraSure Technologies Announces Actions to Enhance Stockholder Value

05 Jan 2022 07:05:00 By Nasdaq GlobeNewswire

OraSure Technologies Announces 2022 Annual Meeting Date

14 Dec 2021 07:05:00 By Nasdaq GlobeNewswire

OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery of the HIV Virus

30 Nov 2021 07:05:00 By Nasdaq GlobeNewswire

OraSure Technologies to Present at Upcoming Investor Conferences

19 Nov 2021 07:05:00 By Nasdaq GlobeNewswire

OraSure Technologies Announces the Retirement of Jack E. Jerrett and Appointment of Agnieszka M. Gallagher as General Counsel, Chief Compliance Officer and Secretary

09 Nov 2021 07:05:00 By Nasdaq GlobeNewswire

OraSure Technologies Appoints Two New Members to the Board of Directors

08 Nov 2021 07:05:00 By Nasdaq GlobeNewswire

OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contracts Positioning the Company for Significant InteliSwab™ Growth in FY22

03 Nov 2021 16:05:02 By Nasdaq GlobeNewswire

U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection

02 Nov 2021 07:05:00 By Nasdaq GlobeNewswire

OraSure Technologies 2021 Third Quarter Earnings Conference Call Wednesday, November 3, 2021, 5:00 p.m. ET

27 Oct 2021 07:05:00 By Nasdaq GlobeNewswire